Palomino Laboratories (PALX) Common Equity (2022 - 2025)

Palomino Laboratories (PALX) has 4 years of Common Equity data on file, last reported at $8.1 million in Q4 2025.

• For the quarter ending Q4 2025, Common Equity rose 44335.15% year-over-year to $8.1 million; the trailing twelve-month figure through Dec 2025 stood at $8.1 million (up 44335.15% YoY), and the FY2025 full-year result was $8.1 million, up 44335.15% from the prior year.
• Common Equity climbed to $8.1 million in Q4 2025, from $7.3 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $8.1 million in Q4 2025 to a low of -$991653.0 in Q1 2025.
• A 4-year average of $1.3 million and a median of -$18306.0 in 2023 frame the typical range for Common Equity.
• Peak annual rise in Common Equity reached 87763.29% in 2025, while the deepest fall reached 42008.41% in 2025.
• Tracing PALX's Common Equity over 4 years: stood at -$27804.0 in 2022, then surged by 34.16% to -$18306.0 in 2023, then changed by 0.0% to -$18306.0 in 2024, then jumped by 44335.15% to $8.1 million in 2025.
• Business Quant data shows PALX's Common Equity at $8.1 million in Q4 2025, $7.3 million in Q3 2025, and -$447236.0 in Q2 2025.